The FDA has approved the first prescription, at-home neuromodulation therapy for individuals with major depressive disorder ...

The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under ...

The FDA has approved ProlivRx, the first prescription, home-based brain neuromodulation therapy, as an adjunctive treatment ...

CORAL SPRINGS, Fla., Jan. 12, 2026 /PRNewswire/ -- Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today announced that the U.S. Food and ...

At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.

SEOUL, South Korea--(BUSINESS WIRE)--Professor Kim Jae-ho of the Department of Neurology at Hallym University Dongtan Sacred Heart Hospital delivered a presentation titled “Transcranial Focused ...

Neurolief announced today that the FDA granted approval for its Proliv Rx at-home neuromodulation therapy for treating depression.

Prescription neuromodulation can be administered outside the clinic with physician oversig ...

With its expansion into St. Louis, Restore Brain continues its mission to broaden access to advanced psychiatric treatments ...

For individuals with major depressive disorder (MDD) that does not respond to pharmacotherapy, recent decisions by the U.S.

First customer sites include the University of Arkansas for Medical Sciences, MUSC Health, and Calif.-based Acacia Clinics and Kaizen Brain Center BURLINGAME, Calif.--(BUSINESS WIRE)--Magnus Medical, ...